timsTOF SCP - Expanding the Horizons of Single Cell Research
Mass spectrometric proteomics has become a staple of modern research in understanding biological function and disease mechanisms. Healthy or diseased tissues that seem homogenous are composed of cells with a variety of different proteomes. Deciphering the proteome of each single cell is key to fully understanding its function and has traditionally presented a major challenge.
Microinjecting CRISPR: Options and key considerations for creating transgenic animal models
CRISPR is revolutionizing the life sciences. Genome editing using RNA-programmable nucleases opens up a wealth of experimental options. At the same time, it makes creating new cell and animal models faster, easier and cheaper than in the past. Consequently, researchers in areas as diverse as cell/developmental biology, genetics or clinical research are turning to CRISPR as their method of choice.
Horizon Discovery: The Power of Personalized Medicine
Learn about how Personalized Medicine is changing how drugs are being developed and how healthcare is being delivered, and how Horizon is helping to enable this change.
Loss-of-Function Genetic Screens with RNAi and CRISPR Libraries
Loss-of-function genetic screens with pooled sgRNA and shRNA libraries aid in discovery / prioritization of drug targets, understanding of disease progression and gene-disease associations, analysis of signal transduction pathways, characterization of the mechanisms for compounds, uncovering of synergistic gene interactions, and identification of markers of drug resistance and sensitivity. This webinar presents a comparison of loss-of-function genetic screens performed with CRISPR versus RNAi technology.
Behind the Science, ep. 13: SPE vs. matrix effects – battle episode!
Driving Innovation in Antibody Discovery and Development Through Novel Partnership Models
In this webinar, Dr Robert Williams, Chief Development Scientist, Cancer Research UK, will discuss how partnership between academia and industry can accelerate drug development.
Progress of Microreaction Technology: from Lab to Industrial Applications
Guangwen Chen, Professor, Dalian Institute Of Chemical Physics, speaking at Flow Chemistry Congress.
High Content Biology & Cardiac Regeneration: Proliferation and Multi-lineage Differentiation Screens using Cardiac Progenitor Cells
Lauren Drowley, Associate Principal Scientist, AstraZeneca, speaking at Stem Cells in Drug Discovery.
Design, Validation and Evaluation of a Bioaffinity based Flow-biochemistry Device
Andras Guttman, Adjunct Professor, Northeastern University, speaking at Flow Chemistry Congress.
iPS Cells for Muscle Disorders: From Regenerative Medicine to Disease Modelling
I will discuss hurdles for the development of therapies for muscle disorders. I will present our platforms based upon iPS cells, inducible myogenesis and human artificial chromosomes. Extension of these technologies for tissue engineering and drug development will also be discussed.
Flow Reactors with Polymeric Membranes for Catalytic Aerobic Partial Oxidation Chemistry in Pharmaceuticals and Specialty Chemicals
Thatcher Root, Professor of Chemical and Biological Engineering, University of Wisconsin, speaking at Flow Chemistry Congress.